Kevin M. Brady, CFO and Treasurer of Medpace Holdings, Inc. (NASDAQ:MEDP), filed a Form 4 on August 24, 2026, disclosing the exercise of employee stock options and a same-day sale of 3,400 shares of common stock on August 20, 2026.

Key Highlights

  • Option exercise: Brady exercised an employee stock option for 3,400 shares of common stock at an exercise price of $138.87 per share on August 20, 2026.
  • Shares sold: 3,400 shares of common stock were disposed of at a price of $625.24 per share on August 20, 2026.
  • Post-transaction ownership: Following the reported transactions, Brady directly owns 12,830 shares of common stock.
  • Remaining options: Brady holds 3,403 employee stock options directly following the reported transaction, with an expiration date of August 15, 2027.
  • Option vesting: According to the filing, the exercised option "vested in full on February 15, 2026."
  • Transaction plan: The filing states the sale "was effected pursuant to a limit order placed by the Reporting Person during an open window period."

Brady's Option Exercise and Share Sale at Medpace Holdings

According to the filing, Kevin M. Brady, serving as CFO and Treasurer of Medpace Holdings, Inc., reported two transactions in the company's common stock on August 20, 2026. First, Brady exercised an employee stock option (transaction code M) to acquire 3,400 shares at the option's exercise price of $138.87 per share. Immediately prior to the sale, Brady's direct beneficial ownership stood at 16,230 shares following that acquisition.

In a same-day transaction (transaction code S), Brady disposed of 3,400 shares at $625.24 per share. The filing notes the sale was made pursuant to a limit order placed during an open window period. After both transactions were completed, Brady's direct ownership in Medpace Holdings common stock totaled 12,830 shares, as reported in Table I of the Form 4.

On the derivative securities side, the filing reports that the exercised employee stock option originally carried an exercise price of $138.87, with an expiration date of August 15, 2027, and had vested in full on February 15, 2026. Following the exercise of 3,400 options, Brady retains 3,403 employee stock options held directly, as reported in Table II. The Form 4 was signed by Stephen P. Ewald as Attorney-in-Fact for Kevin M. Brady and filed on August 24, 2026.

What Was Disclosed

The Form 4 discloses that Medpace Holdings CFO Kevin M. Brady exercised 3,400 employee stock options at $138.87 and sold 3,400 shares at $625.24 on August 20, 2026, leaving him with direct ownership of 12,830 common shares and 3,403 remaining options.